Clinical Trials Logo

Clinical Trial Summary

Bardet-Biedl syndrome (BBS; OMIN #209900) is a rare genetic disorder characterized by six core features: rod-cone dystrophy (retinitis pigmentosa), polydactyly, obesity, genital anomalies, renal anomalies, and learning difficulties. This study aims to contribute to genetic and medical knowledge of BBS, and to provide information on quality of life in adults with BBS and their close relatives. Participants will undergo medical assessments (ocular, oral, and physical examinations) and self-reporting of quality of life, diet, cognitive and emotional symptoms. There are some known genotype-phenotype associations in BBS and participants will be offered genetic testing. It is important to map both genotype and associated phenotype in order to provide optimal treatment and follow-up. Individuals with BBS, age 16 years or older, will be invited to participate. The investigators expect to enroll at least 25 male and female adults with BBS and 15 of their parents to participate in qualitative interviews. These interviews will investigate parents' experiences having a child with BBS, satisfaction with health care services, experience with social and family life, and psychological health.


Clinical Trial Description

Improved care for adults with BBS living in Norway necessitates increased knowledge of pertinent health-related, emotional, and educational, employment and psychosocial issues. Adults with BBS living in Norway may face new challenges and have unmet healthcare needs. Therefore, the investigators intend to evaluate the adult with BBS as a person with special needs (e.g. need for support systems, lack of social opportunities, and mental health problems) and long-term challenges.This project will describe the visual, medical, physical, nutritional, and psychological difficulties experienced by people with BBS. The planned multi-disciplinary clinical evaluation in this study can help address the existing knowledge gaps. Relatives who help their loved ones with various activities of daily living may experience reduced quality of life and altered social roles. Therefore, the investigators also want to study the quality of life and psychological status of close relatives. This project might contribute information for new clinical protocols and suggest areas for further research in genetics, healthcare needs and quality of life for people living with BBS. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05400278
Study type Observational
Source Oslo University Hospital
Contact
Status Enrolling by invitation
Phase
Start date February 1, 2022
Completion date December 31, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT04874909 - Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) N/A
Recruiting NCT02329210 - Clinical Registry Investigating Bardet-Biedl Syndrome
Recruiting NCT02435940 - Inherited Retinal Degenerative Disease Registry
Completed NCT00213811 - Bardet-Biedl Syndrome Study: Clinical and Genetic Epidemiology Study in Adults N/A
Recruiting NCT04461444 - COhort for Bardet-Bield Syndrome and Alström Syndrome for Translational Research Monocentric Interventional Study N/A
Recruiting NCT06239064 - Early Genetic Identification of Obesity
Terminated NCT00078091 - Genetics and Clinical Characteristics of Bardet-Biedl Syndrome
Completed NCT04966741 - Setmelanotide in Pediatric Patients With Rare Genetic Diseases of Obesity Phase 3
Completed NCT05194124 - Phase 3 Crossover Trial of Two Formulations of Setmelanotide in Patients With Specific Gene Defects in the MC4R Pathway Phase 3
Withdrawn NCT03490019 - Treatment of Bardet-Biedl-Syndrome With Metformin for Evaluation of a Possible Visual Improvement Phase 2